Moneycontrol PRO
UPCOMING EVENT:Moneycontrol Pro & Espresso (A Sharekhan Company) in association with Intrazon 2.0 bring to you India’s Largest Retail Intraday Traders Online Conference. Learn 12 Amazing Strategies from 12 Intraday Traders @ Rs. 600/-. Register Now!

Natco Pharma raises Rs 915 crore via QIP

Specific details about utilisation of the proceeds were not disclosed.

December 14, 2017 / 06:11 PM IST
Myth 3: Everyone who has a mental illness needs medication to manage symptoms | Bulthuis says no two patients are the same. While medicines can help manage symptoms, there are some people with mental illness who do not require medication. For others, medicine is essential for recovery. (Representative image)

Myth 3: Everyone who has a mental illness needs medication to manage symptoms | Bulthuis says no two patients are the same. While medicines can help manage symptoms, there are some people with mental illness who do not require medication. For others, medicine is essential for recovery. (Representative image)

Natco Pharma has raised Rs 915 crore through issue of securities to qualified institutional investors, according to a regulatory filing.

During its meeting on Thursday, the company's committee of directors decided to allocate 1 crore shares at issue price of Rs 915 apiece, Natco Pharma said.

The shares were allotted to eligible qualified institutional buyers pursuant to the QIP amounting to an issue size of Rs 915 crore, it added.

Specific details about utilisation of the proceeds were not disclosed.

Shares of the company surged 6.08 percent to close at Rs 1,020.85 apiece on the BSE on Thursday.
PTI
first published: Dec 14, 2017 05:53 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark